![]() |
FDA Regulator Defends Revoking Avastin For Breast Cancer Use
The head of FDA's cancer division is defending the agency's decision last month to revoke approval of Genentech's Avastin for breast cancer treatment, the Wall Street Journal reports (Mundy, Wall Street Journal, 1/7)...
More... |
| All times are GMT -7. The time now is 11:47 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021